FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

37123411000001103: Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
201161000001119 Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
201171000001112 Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has AMP Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Is a Naratriptan 2.5mg tablets 12 tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has specific active ingredient Naratriptan hydrochloride true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Mawdsley-Brooks & Company Ltd) 12 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start